Compounding pharmacies with FDA records, by state
Which compounding pharmacies have FDA records?
GLP-1 Ledger has a page for each of 460 compounding pharmacies and outsourcing facilities in 46 states named in FDA records: 100 on FDA’s registered outsourcing facility list (updated Nov 6, 2026) and 396 with an entry on FDA’s compounding inspections and actions page (current as of Oct 22, 2026), 104 of them with at least one FDA warning letter listed there. State board of pharmacy license records and board actions are checked for California, Colorado, Connecticut, Delaware, Florida, Illinois, Michigan and Texas, and board actions alone for Maryland, New York, Tennessee and Virginia; other states are not checked.
Each pharmacy page answers from the record whether FDA’s 503B list names it, whether its state board lists a license under the same name and city (where this index reads that board), and which FDA letters and board actions are listed for it. Records for the same pharmacy are merged only when the name, city and state match. The full list is in the pharmacies CSV.
| Alabama | 6 | 2 | 5 | 1 |
| Alaska | 1 | 0 | 1 | 0 |
| Arizona | 16 | 2 | 15 | 7 |
| Arkansas | 8 | 3 | 7 | 1 |
| California | 54 | 8 | 48 | 10 |
| Colorado | 14 | 4 | 14 | 2 |
| Connecticut | 8 | 2 | 7 | 0 |
| Florida | 48 | 16 | 36 | 14 |
| Georgia | 6 | 0 | 6 | 1 |
| Hawaii | 1 | 0 | 1 | 1 |
| Idaho | 4 | 0 | 4 | 0 |
| Illinois | 10 | 0 | 10 | 1 |
| Indiana | 5 | 0 | 5 | 1 |
| Kansas | 8 | 1 | 7 | 1 |
| Kentucky | 4 | 0 | 4 | 2 |
| Louisiana | 5 | 0 | 5 | 1 |
| Maine | 3 | 0 | 3 | 0 |
| Maryland | 7 | 1 | 6 | 0 |
| Massachusetts | 4 | 1 | 4 | 1 |
| Michigan | 4 | 0 | 4 | 1 |
| Minnesota | 7 | 1 | 6 | 1 |
| Mississippi | 5 | 1 | 5 | 1 |
| Missouri | 10 | 3 | 8 | 2 |
| Montana | 4 | 1 | 4 | 2 |
| Nebraska | 2 | 1 | 2 | 1 |
| Nevada | 7 | 3 | 5 | 3 |
| New Hampshire | 1 | 0 | 1 | 0 |
| New Jersey | 26 | 8 | 21 | 7 |
| New York | 19 | 2 | 17 | 5 |
| North Carolina | 11 | 1 | 11 | 6 |
| Ohio | 12 | 3 | 11 | 2 |
| Oklahoma | 7 | 2 | 6 | 0 |
| Oregon | 4 | 0 | 4 | 1 |
| Pennsylvania | 18 | 6 | 15 | 5 |
| Puerto Rico | 1 | 1 | 0 | 0 |
| Rhode Island | 1 | 0 | 1 | 0 |
| South Carolina | 10 | 2 | 8 | 2 |
| South Dakota | 1 | 0 | 1 | 0 |
| Tennessee | 15 | 4 | 11 | 3 |
| Texas | 57 | 17 | 44 | 14 |
| Utah | 2 | 0 | 2 | 0 |
| Vermont | 1 | 0 | 1 | 0 |
| Virginia | 9 | 2 | 8 | 3 |
| Washington | 9 | 0 | 9 | 0 |
| West Virginia | 1 | 0 | 1 | 0 |
| Wisconsin | 2 | 1 | 1 | 0 |
No state given
FDA’s entry gives no city or state for these, so they are not on a state page.
| Orion Specialty Labs, LLC | Not given | 503B | Record found | No match possible | 0 | 0 | None listed |
| Texas Longhorn Rx, LLC | Not given | Not stated | No match possible | No match possible | 0 | 1 | Aug 30, 2022 |
This page restates FDA’s lists. A Form 483 or letter is not a finding by this site, and a missing record is not a finding either way. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
Records last pulled Nov 15, 2026. Every entry links to the original public record.